Impacting an estimated 1 to 10 per million people, familial chylomicronemia syndrome is a rare form of severe hypertriglyceridemia that prevents the body from breaking down and removing ...

In FCS, mutations in the lipoprotein lipase gene lead to an accumulation of chylomicrons in plasma resulting in severe hypertriglyceridemia.

Severe hypertriglyceridemia (≥500 mg/dl [5.65 mmol/l]) should be treated to reduce the risk of pancreatitis. The omega-3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA ...

Arrowhead Pharmaceuticals said Friday that the Food and Drug Administration accepted the company's new drug application for its treatment of familial chylomicronemia syndrome, a severe and rare ...